Recent Episodes
CAR-T in 2025: Advancements and the Road Ahead
Jason Westin, M.D., MS, FACP, MD Anderson Cancer Center, Houston, TX
Exploring Cutaneous T-Cell Lymphoma
Jaehyuk (Jae) Choi, MD, Northwestern University Feinberg School of Medicine, Chicago, IL
Highlights from Attending ASH 2024
Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY
Advancing Treatment Strategies: The Role of Bispecific Antibodies in Lymphoma
Celeste Bello, MD, Moffitt Cancer Center, Tampa, FL
Understanding Mental Health in Cancer Survivorship
Lynn Gooden, BSN, RN, ONN-CG, Community Health Network MD Anderson Cancer Center, Indianapolis, IN and Cassie Osborne, MSN, RN, OCN, ONN-CG, Community Health Network MD Anderson Cancer Center, Indianapolis, IN
What’s New in Chronic Lymphocytic Leukemia (CLL)?
Kerry A. Rogers, MD, The Ohio State University, Columbus, OH
Categories
- All Episodes (94)
- CAR T-cell Therapy (11)
- Clinical Trials (4)
- COVID-19 (7)
- General Treatment & Support (31)
- Genomics (3)
- Health Equity (8)
- Leukemia (22)
- Lymphoma (15)
- Minimal Residual Disease (MRD) (4)
- Myelodysplastic Syndromes (5)
- Myeloma & Amyloidosis (13)
- Myeloproliferative Neoplasms (3)
- Pediatric and AYA (12)
- Rare Blood Cancers (4)
- Transplantation (4)
- Waldenström macroglobulinemia (2)